Sarcopenic Obesity, Functional Outcomes, and Systemic Inflammation in Patients With Chronic Obstructive Pulmonary Disease

Journal of the American Medical Directors Association

Volumn 17, Issue 8, 2016, Pages 712-718

  Joppa, Pavol ^a,b   Tkacova, Ruzena ^a   Franssen, Frits M E ^b   Hanson, Corrine ^c   Rennard, Stephen I ^c,d   Silverman, Edwin K ^e,f   McDonald, Merry Lynn N ^e   Calverley, Peter M A ^g   Tal Singer, Ruth ^h   Spruit, Martijn A ^b,i   Kenn, Klaus ^j   Wouters, Emiel F M ^b,k   Rutten, Erica P A ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b CIRO   (Netherlands)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d ASTRAZENECA   (United Kingdom)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF LIVERPOOL   (United Kingdom)

^h GLAXOSMITHKLINE   (United States)

ⁱ HASSELT UNIVERSITY   (Belgium)

^j Schoen Klinik Berchtesgadener Land   (Germany)

^k MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

6 minute walking distance; Body composition; chronic obstructive pulmonary disease; fibrinogen; sarcopenic obesity; systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXERCISE TOLERANCE; FEMALE; FIBRINOGEN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HUMAN; IMPEDANCE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OBESITY; PROTEIN BLOOD LEVEL; SARCOPENIA; SARCOPENIC OBESITY; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; COMORBIDITY; HEALTH STATUS; LONGITUDINAL STUDY; MIDDLE AGED; OBSERVATIONAL STUDY;

AGED; COMORBIDITY; FEMALE; HEALTH STATUS; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OBESITY; OBSERVATIONAL STUDIES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SARCOPENIA;

EID: 84964950577     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.03.020     Document Type: Article

References (36)

1. 1 Vanfleteren, L.E., Spruit, M.A., Groenen, M., et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187 (2013), 728–735.
2. 2 Steuten, L.M., Creutzberg, E.C., Vrijhoef, H.J., Wouters, E.F., COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J 15 (2006), 84–91.
3. 3 Rutten, E.P., Calverley, P.M., Casaburi, R., et al. Changes in body composition in patients with chronic obstructive pulmonary disease: Do they influence patient-related outcomes?. Ann Nutr Metab 63 (2013), 239–247.
4. 4 Ischaki, E., Papatheodorou, G., Gaki, E., et al. Body mass and fat-free mass indices in COPD: Relation with variables expressing disease severity. Chest 132 (2007), 164–169.
5. 5 Van de Bool, C., Rutten, E.P., Franssen, F.M., et al. Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. Eur Respir J 46 (2015), 336–345.
6. 6 Shoup, R., Dalsky, G., Warner, S., et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J 10 (1997), 1576–1580.
7. 7 Schols, A.M., Broekhuizen, R., Weling-Scheepers, C.A., Wouters, E.F., Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82 (2005), 53–59.
8. 8 Vestbo, J., Prescott, E., Almdal, T., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: Findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173 (2006), 79–83.
9. 9 Jousilahti, P., Tuomilehto, J., Vartiainen, E., et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation 93 (1996), 1372–1379.
10. 10 Festa, A., D'Agostino, R. Jr., Williams, K., et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25 (2001), 1407–1415.
11. 11 Yudkin, J.S., Kumari, M., Humphries, S.E., Mohamed-Ali, V., Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?. Atherosclerosis 148 (2000), 209–214.
12. 12 Rutten, E.P., Breyer, M.K., Spruit, M.A., et al. Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease. Clin Nutr 29 (2010), 756–760.
13. 13 Ryu, M., Jo, J., Lee, Y., et al. Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: The Fourth Korea National Health and Nutrition Examination Survey. Age Ageing 42 (2013), 734–740.
14. 14 Kim, J.H., Cho, J.J., Park, Y.S., Relationship between sarcopenic obesity and cardiovascular disease risk as estimated by the Framingham risk score. J Korean Med Sci 30 (2015), 264–271.
15. 15 Atkins, J.L., Whincup, P.H., Morris, R.W., et al. Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men. J Am Geriatr Soc 62 (2014), 253–260.
16. 16 Furutate, R., Ishii, T., Wakabayashi, R., et al. Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 6 (2011), 423–430.
17. 17 Vestbo, J., Anderson, W., Coxson, H.O., et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 31 (2008), 869–873.
18. 18 Agusti, A., Calverley, P.M., Celli, B., et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res, 11, 2010, 122.
19. 19 Miller, M.R., Hankinson, J., Brusasco, V., et al. Standardisation of spirometry. Eur Respir J 26 (2005), 319–338.
20. 20 ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002), 111–117.
21. 21 Meguro, M., Barley, E.A., Spencer, S., Jones, P.W., Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 132 (2007), 456–463.
22. 22 Agustí, A., Edwards, L.D., Rennard, S., et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One, 7, 2012, e37483.
23. 23 Steiner, M.C., Barton, R.L., Singh, S.J., Morgan, M.D., Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19 (2002), 626–631.
24. 24 Franssen, F.M., Rutten, E.P., Groenen, M.T., et al. New reference values for body composition by bioelectrical impedance analysis in the general population: Results from the UK Biobank. J Am Med Dir Assoc 15 (2014), 448.e1–448.e6.
25. 25 Mostert, R., Goris, A., Weling-Scheepers, C., et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med 94 (2000), 859–867.
26. 26 Spruit, M.A., Watkins, M.L., Edwards, L.D., et al. Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort. Respir Med 104 (2010), 849–857.
27. 27 Ora, J., Laveneziana, P., Ofir, D., et al. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med 180 (2009), 964–971.
28. 28 Ora, J., Laveneziana, P., Wadell, K., et al. Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol (1985) 111 (2011), 10–19.
29. 29 Sava, F., Laviolette, L., Bernard, S., et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med, 10, 2010, 55.
30. 30 Koo, H.K., Park, J.H., Park, H.K., et al. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean National Health and Nutrition Examination Survey. PLoS One, 9, 2014, e110448.
31. 31 Fox, C.S., Massaro, J.M., Hoffmann, U., et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 116 (2007), 39–48.
32. 32 Van den Borst, B., Gosker, H.R., Wesseling, G., et al. Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr 94 (2011), 1504–1512.
33. 33 Tkacova, R., Ukropec, J., Skyba, P., et al. Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Respiration 81 (2011), 386–393.
34. 34 Biolo, G., Cederholm, T., Muscaritoli, M., Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia. Clin Nutr 33 (2014), 737–748.
35. 35 Schols, A.M., Ferreira, I.M., Franssen, F.M., et al. Nutritional assessment and therapy in COPD: A European Respiratory Society statement. Eur Respir J 44 (2014), 1504–1520.
36. 36 Kim, T.N., Park, M.S., Lim, K.I., et al. Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Res Clin Pract 93 (2011), 285–291.